CAMPATH vs IMBRUVICA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. CAMPATH and IMBRUVICA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAMPATH	IMBRUVICA
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ALEMTUZUMAB	IBRUTINIB
Manufacturer	Genzyme	Pharmacyclics LLC
Dosage forms	Injectable	Capsule, Suspension, Tablet
Drug class	Cd52-Directed Cytolytic Antibody	—
Boxed warning	Boxed warning	None
Treats	B-Cell Chronic Lymphocytic Leukemia	Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma

campath imbruvica

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

ALEMTUZUMAB

IBRUTINIB

Manufacturer

Genzyme

Pharmacyclics LLC

Dosage forms

Injectable

Capsule, Suspension, Tablet

Drug class

Cd52-Directed Cytolytic Antibody

—

Boxed warning

None

Treats

B-Cell Chronic Lymphocytic Leukemia

Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma

Frequently asked questions

What is the difference between Campath and Imbruvica?

Campath contains Alemtuzumab, while Imbruvica contains Ibrutinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.